Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery
- 1 September 2006
- journal article
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 53 (9) , 926-933
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot studyBritish Journal of Anaesthesia, 2005
- Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgeryEuropean Journal of Cardio-Thoracic Surgery, 2005
- Off-Label Use of Recombinant Factor VIIA Concentrates After Cardiac SurgeryThe Annals of Thoracic Surgery, 2005
- Recombinant Factor VIIa in the Treatment of Postoperative Hemorrhage After Cardiac SurgeryThe Annals of Thoracic Surgery, 2005
- Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task ForceJournal of Thrombosis and Haemostasis, 2005
- Recombinant factor VIIaThrombosis and Haemostasis, 2005
- Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score–matched case‐control analysisTransfusion, 2004
- Transfusion of Blood Products Affects Outcome in Cardiac SurgerySeminars in Cardiothoracic and Vascular Anesthesia, 2004
- The independent association of massive blood loss with mortality in cardiac surgeryTransfusion, 2004
- Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhageThrombosis Journal, 2004